470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors

MLA

Joshua T. Walker, et al. “470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-Specific Killer Engager and Off-the-Shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors.” Journal for ImmunoTherapy of Cancer, vol. 8, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a4d067c8a4c62c532973385644ee9c1e&authtype=sso&custid=ns315887.

APA

Joshua T. Walker, Martin Felices, Frank Cichocki, Ryan Bjordahl, Bahram Valamehr, Jeffrey S. Miller, Alexander J. Lenvik, Daniel A. Vallera, Zachary Davis, Nicholas A. Zorko, Todd Lenvik, Alejandro Garcia, Thomas H. Lee, Behiye Kodal, & Svetlana Gaidarova. (2020). 470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors. Journal for ImmunoTherapy of Cancer, 8.

Chicago

Joshua T. Walker, Martin Felices, Frank Cichocki, Ryan Bjordahl, Bahram Valamehr, Jeffrey S. Miller, Alexander J. Lenvik, et al. 2020. “470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-Specific Killer Engager and Off-the-Shelf NK Cell Therapy Enhances Specificity and Function Against a Broad Range of Solid Tumors.” Journal for ImmunoTherapy of Cancer 8 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a4d067c8a4c62c532973385644ee9c1e&authtype=sso&custid=ns315887.